Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Oculis Holding AG
OCS · SEC Filings
website
60
Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in ...
Price
7.76
Market Cap
480.5 M
Float
52.79 M
Country
CH
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about OCS
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Oculis Holding AG
OCS · SEC Filings
52.79 M
Float
7.76
Price
480.5 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 4, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 11, 2025
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 19, 2024
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 28, 2023
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 7, 2023
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B5
[No Baby Shelf]* November 2026 ATM | Offering amount: $125,000,000 | Bank: Leerink Partners LLC
Nov 3, 2026
424B3
UPDATED | SHARE RESALE REGISTRATION | Shares amount: 494,259
Dec 1, 2025
424B5
REGISTERED OFFERING
Oct 31, 2025
424B5
REGISTERED OFFERING
Oct 31, 2025
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
Feb 14, 2025
424B3
UPDATED
Sep 6, 2024
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 6, 2026
F-3ASR
March 2026 SHELF + ATM
Mar 4, 2026
POS AM
Form POS AM - Post-Effective amendments for registration statement
Dec 5, 2025
F-3
SHARE RESALE REGISTRATION
Nov 10, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 5, 2025
F-3
SHELF EFFECTIVE
Aug 27, 2024
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
LSP 7 Cooperative UA (Filed by)
Apr 29, 2026
SCHEDULE 13G/A
BVCF IV, L.P. (Filed by)
Mar 27, 2026
144
Form 144 - Report of proposed sale of securities
Mar 9, 2026
SCHEDULE 13G/A
Pivotal bioVenture Partners Fund I, L.P. (Filed by)
Nov 14, 2025
144
Form 144 - Report of proposed sale of securities
Oct 9, 2025
144
Form 144 - Report of proposed sale of securities
Sep 23, 2025
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 9, 2025
EFFECT
Form EFFECT - Notice of Effectiveness
Sep 9, 2024
CORRESP
Form CORRESP - Correspondence
Sep 4, 2024
LETTER
Form UPLOAD - SEC-generated letter
Aug 30, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 4, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 3, 2024
